Group 1 - Veradermics Inc. is seeking to raise up to $213.6 million through an IPO to advance the commercialization of its oral hair restoration medication [1][2] - The company plans to issue 13.4 million shares at a price range of $14 to $16 per share, potentially valuing the company at approximately $534 million [1] - Wellington Management has expressed interest in purchasing up to $30 million worth of shares at the IPO price [1] Group 2 - Founded in 2019, Veradermics is a late-stage clinical biopharmaceutical company developing a non-hormonal treatment for mild to moderate androgenetic alopecia, currently in late-stage clinical trials [2] - Prior to the IPO, Veradermics raised $150 million in a Series C funding round led by SR One, with participation from new investors and existing supporters [2] - The IPO will be led by Jefferies Financial Group, Leerink Partners, Citigroup, and Cantor Fitzgerald, with plans to list on the New York Stock Exchange under the ticker "MANE" [2]

Group 1 - Veradermics Inc. is seeking to raise up to $213.6 million through an IPO to advance the commercialization of its oral hair restoration medication [1][2] - The company plans to issue 13.4 million shares at a price range of $14 to $16 per share, potentially valuing the company at approximately $534 million [1] - Wellington Management has expressed interest in purchasing up to $30 million worth of shares at the IPO price [1] Group 2 - Founded in 2019, Veradermics is a late-stage clinical biopharmaceutical company developing a non-hormonal experimental treatment for mild to moderate androgenetic alopecia [2] - The company previously raised $150 million in a Series C funding round in October, led by SR One, with participation from new investors and existing supporters [2] - The IPO will be led by Jefferies Financial Group, Leerink Partners, Citigroup, and Cantor Fitzgerald, with plans to list on the New York Stock Exchange under the ticker "MANE" [2]

As filed with the Securities and Exchange Commission on January 28, 2026. Registration No. 333-292657 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Veradermics, Incorporated (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 84-3304423 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificat ...

As filed with the Securities and Exchange Commission on January 9, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Veradermics, Incorporated (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 84-3304423 (I.R.S. Employer Identification No.) 470 James St. New ...